tiprankstipranks
Allogene Therapeutics Inc (ALLO)
NASDAQ:ALLO
US Market

Allogene Therapeutics (ALLO) Ownership - Who Owns Allogene Therapeutics?

1,092 Followers

Allogene Therapeutics (ALLO) Ownership Overview

31.64%24.33%32.65%11.38%
31.64% Insiders
32.65% Other Institutional Investors
11.38% Public Companies and Individual Investors
The ownership structure of Allogene Therapeutics (ALLO) stock is a mix of institutional, retail and individual investors. Approximately 56.98% of the company’s stock is owned by Institutional Investors, 31.64% is owned by Insiders and 11.38% is owned by Public Companies and Individual Investors.
The ownership structure of Allogene Therapeutics (ALLO) stock is a mix of institutional, retail and individual investors. Approximately 56.98% of the company’s stock is owned by Institutional Investors, 31.64% is owned by Insiders and 11.38% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
May 20, 2024Bought$4999997
Mar 06, 2024Bought$682
Aug 09, 2023
Stephen Mayo
Director
Sold$42800

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2024Sold$133273
Mar 31, 2024Sold$1927401
Mar 31, 2024Bought$11773872
Mar 31, 2024Bought$24354285

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
7,923,697Institution3.80%19,967,716
7,799,138Institution3.74%19,653,828
6,930,552Institution3.32%17,464,991
6,277,888Institution3.01%15,820,278
5,448,386Institution2.61%13,729,933
5,310,109Institution2.54%13,381,475
4,567,977Institution2.19%11,511,302
4,121,552Institution1.97%10,386,311
3,604,600Institution1.73%9,083,592
3,410,455Institution1.63%8,594,347

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
7,923,697Institution3.80%19,967,716
6,277,888Institution3.01%15,820,278
5,310,109Institution2.54%13,381,475
4,121,552Institution1.97%10,386,311
3,604,600Institution1.73%9,083,592
3,410,455Institution1.63%8,594,347
3,377,879Institution1.62%8,512,255
2,138,882Institution1.02%5,389,983
1,881,671Institution0.90%4,741,811
1,678,192Institution0.80%4,229,044

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
6,525,786Institution3.13%16,575,496
3,351,609Institution1.61%9,250,441
2,206,135Institution1.06%5,559,460
1,645,813Institution0.79%4,542,444
1,283,935Institution0.61%3,543,661
847,984Institution0.41%2,136,920
725,877Institution0.35%2,003,421
741,043Institution0.35%1,867,428
535,309Institution0.26%1,359,685
413,477Institution0.20%1,050,232

FAQ

Who Owns Allogene Therapeutics Inc (ALLO)?
According to the latest TipRanks data, approximately 32.65% of the company's stock is held by institutional investors, 31.64% is held by insiders, and 11.38% is held by retail investors.
    What percentage of Allogene Therapeutics Inc (ALLO) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 32.65% of Allogene Therapeutics Inc (ALLO) stock is held by institutional investors.
      What percentage of Allogene Therapeutics Inc (ALLO) stock is held by retail investors?
      According to the latest TipRanks data, approximately 11.38% of Allogene Therapeutics Inc (ALLO) stock is held by retail investors.
        Who owns the most shares of Allogene Therapeutics Inc (ALLO)?
        VANGUARD INDEX FUNDS owns the most shares of Allogene Therapeutics Inc (ALLO).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis